This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

PCC 2024 — Pharmaceutical Compliance Congress


  • 00
  • 00
  • 00
  • 00
Delivered as a Hybrid Event
April 16-18, 2024The Ritz-Carlton, Tysons Corner | McLean, VA

Awet Gerbrehiwet-Wilder
US Head of Auditing and Monitoring, Integrity & Compliance at Indivior


Awet Gebrehiiwet-Wilder has over 20 years of life sciences experience encompassing, sales, marketing, compliance, and product testing and manufacturing. Her subject matter expertise includes managing the risks associated with relationships between field personnel and external healthcare professionals, which encompasses both commercial and non-promotional activities; sales effectiveness and target messaging, improving compliance program effectiveness through program development and rollout; compliance risk assessments; corrective action development; and monitoring.

Awet’s previous roles focused on supporting Commercial, Sales, and Compliance Operations with Field Force Monitoring program development and implementation, Records Review, and Data Analytics, to create a robust and comprehensive program to identify current and potential new risk trends.

Awet has significant sales, compliance, and marketing experience within the following therapeutic areas: Aesthetics, Injectables, Breast Implants, Tissue Mesh, Medical Devices, Oncology, Cardiology, Urology, Neurology, Ophthalmology, Dermatology, Metabolic Diseases, Orthopedics, Opioids, Multiple Sclerosis, Pulmonology, Cardiology, Psychiatry, and Rare Diseases.

Agenda Sessions

  • Artificial Intelligence in Life Sciences Compliance